Mc Collum Christoferson Group LLC Virios Therapeutics, Inc. Transaction History
Mc Collum Christoferson Group LLC
- $328 Million
- Q1 2024
A detailed history of Mc Collum Christoferson Group LLC transactions in Virios Therapeutics, Inc. stock. As of the latest transaction made, Mc Collum Christoferson Group LLC holds 42,000 shares of VIRI stock, worth $10,080. This represents 0.01% of its overall portfolio holdings.
Number of Shares
42,000
Previous 37,000
13.51%
Holding current value
$10,080
Previous $21,000
4.76%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding VIRI
# of Institutions
22Shares Held
681KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA209KShares$50,1310.0% of portfolio
-
Geode Capital Management, LLC Boston, MA174KShares$41,8720.0% of portfolio
-
State Street Corp Boston, MA52.8KShares$12,6780.0% of portfolio
-
Raymond James & Associates St Petersburg, FL30KShares$7,2000.0% of portfolio
-
Northern Trust Corp Chicago, IL24KShares$5,7680.0% of portfolio
About Virios Therapeutics, Inc.
- Ticker VIRI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,330,400
- Market Cap $4.4M
- Description
- Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...